SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors closely monitor the upcoming CHMP opinion regarding its Alzheimer's drug, Blarcamesine, with discussions focused on the potential for EU approval and the implications of an oral explanation procedure. The community is weighing the significance of the presentation and its possible impact on the final decision, while also debating the influence of shorts and market manipulation on the stock's price. Some investors believe approval is imminent, citing the drug's safety profile and convenience compared to existing treatments, while others remain cautious due to past trial results and potential regulatory hurdles.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano Inc. ($MOVE) is trending due to news of a Nasdaq listing extension, easing delisting concerns and attracting traders seeking quick gains. The community is actively discussing the stock's low float and potential for a short squeeze, with some eyeing sympathy plays in similar tickers. Speculation around future financial reports and AI integration from a potential merger are also fueling the conversation.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health (OSCR) is trending due to uncertainty surrounding the extension of ACA subsidies and their potential impact on the company's future profitability. While some believe that the absence of subsidies could benefit OSCR's individual market focus, others are concerned about reduced affordability for consumers and the company's revenue. Community discussions also focus on technical analysis, potential catalysts, and speculation about a short squeeze.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending amid discussions surrounding a potential acquisition of Northern Data, with the community focused on the deal's implications for the platform's GPU and AI capabilities. Talk centers around Tether's growing investment in Rumble and its potential to boost the company's growth in the long term. Investors are also weighing upcoming earnings and the launch of Rumble Wallet.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

GLTO is trending due to a recent acquisition and a substantial funding round, igniting discussions around a potential short squeeze given the low float and high cost to borrow. Community members are actively debating entry and exit strategies amidst the stock's volatile price action and trading halts. The focus is on potential gains from a squeeze, while some caution against chasing the momentum.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending with increased community enthusiasm, as traders express bullish sentiment using the hashtag WAGMI. Discussions suggest an accumulation phase is ending, with some anticipating a significant upward movement. Broader conversations touch upon market structure and potential breakouts.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as the community debates the implications of recent price action relative to the company's cash position and profitability. Discussions include speculation on short positions, potential for a short squeeze, and potential catalysts. Some traders are expressing frustration with the stock's performance and leadership's communication strategy.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Papa John's is trending amid renewed takeover speculation, with reports suggesting a potential bid from Irth Capital Management. Community chatter revolves around the potential deal's valuation and likelihood, especially given past failed attempts, while some express hope for a bidding war. The stock's recent price surge reflects this speculative interest within the restaurant sector.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending with growing anticipation for the AASLD Liver Meeting in November, where new data is expected to be revealed, fueling speculation around potential partnerships or a buyout before the end of the year. Community members are actively discussing the value of Belapectin, especially its potential synergy with GLP-1 drugs, and a possible short squeeze due to high short interest. Some investors speculate on a buyout price in the double digits.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending as investors discuss recent Phase 1 clinical data showing positive results for CTX310, a gene-editing therapy targeting lipid disorders, presented at the AHA Scientific Sessions. While some express disappointment with the market's initial reaction and Q3 EPS, others highlight the potential of this one-time treatment to disrupt the cholesterol drug market and anticipate a significant stock increase. Community members are also debating upcoming earnings, revenue expectations, and potential milestone payments.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Infrastructure firm <a class="stockpage_articles" href="https://www.cnbctv18.com/market/stocks/power-mech-projects-share-price/PMP/" target="_blank" rel="noopener">Power Mech Projects Ltd</a> on Monday (November 10) reported an 11.7% year-on-year increase in net profit at ₹74.92 crore for the quarter ended September 2025, compared with ₹67.07 crore in the same period last year. 
 
Revenue rose 19.5% year-on-year to ₹1,237.8 crore from ₹1,035.4 crore in Q2 FY25. EBITDA increased 19% to ₹147.02 crore from ₹123.56 crore in the year-ago quarter. The company’s operating margin stood at 11.88% for the quarter, slightly lower than 11.94% in the year-ago period. 
 
Also Read: <a href="https://www.cnbctv18.com/market/power-mech-projects-share-price-972-crore-order-win-telangana-power-corporation-impact-19603642.htm">Power Mech Projects shares surge after winning ₹972 crore project in Telangana</a> 
 
Power Mech Projects is known for its strong presence in industrial construction and services, particularly in the power sector. Shares of Power Mech Projects Ltd ended at ₹2,435.00, up by ₹38.15, or 1.59%, on the BSE.

Power Mech Projects Q2 Results | Net profit rises 12% on 20% revenue growth

EBITDA increased 19% to ₹147.02 crore from ₹123.56 crore in the year-ago quarter. The company’s operating margin stood at 11.88% for the quarter, slightly lower than 11.94% in the year-ago period. Shares of Power Mech Projects Ltd ended at ₹2,435.00, up by ₹38.15, or 1.59%, on the BSE.

Equity

Frame 485.png

Get the daily email that keeps you tuned in and makes markets fun again.

Frame 484.png

The most relevant Indian markets intel delivered to you everyday.

cryptotwits - 800x800.png

Get the daily crypto email you’ll actually love to read. It's value-packed, data-driven, and seasoned with wit.

Frame 479.png

The best trade ideas and analysis from the Stocktwits community. Delivered daily by 8 pm ET.

Frame 486.png

For serious investors with a serious sense of humor.

Frame 487.png

High Relative Strength, Low Social Following

Power Mech Projects Q2 Results | Net profit rises 12% on 20% revenue growth

Latest News